Adaptimmune Therapeutics plc (ADAPY) ADS

Sell:$0.02Buy:$0.02Price unchangedNo change

Prices delayed by at least 15 minutes
Sell:$0.02
Buy:$0.02
Change:Price unchangedNo change
Deal now
Prices delayed by at least 15 minutes
Sell:$0.02
Buy:$0.02
Change:Price unchangedNo change
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$0.02
Previous close$0.02
Market cap$5.30m
P/E ratio-
Volume70,020
Dividend yield0.00%
EMS-

Company information

Adaptimmune Therapeutics PLC is focused on pre-clinical programs, including PRAME and CD70-directed T-cell therapies, and its allogeneic pipeline. PRAME is highly expressed across a range of solid tumors, including ...

  • LocationUnited Kingdom
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue1.59bn
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Lightweight Charts™ provided by https://www.tradingview.com/.